Effects of intrathecal injection of ropivacaine on spinal cord in rats based on genomics.
10.11817/j.issn.1672-7347.2022.200991
- Author:
Yuan LIU
1
;
Qulian GUO
2
;
Zhong ZHANG
2
;
E WANG
2
;
Zhihua SUN
3
Author Information
1. Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008, China. 332387962@qq.com.
2. Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008, China.
3. Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008, China. 1036725887@qq.com.
- Publication Type:Journal Article
- Keywords:
genomics;
ropivacaine;
subarachnoid anesthesia
- MeSH:
Animals;
Genomics;
Injections, Spinal;
Male;
Rats;
Rats, Sprague-Dawley;
Ropivacaine;
Spinal Cord/metabolism*
- From:
Journal of Central South University(Medical Sciences)
2022;47(4):431-442
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:There are clinical reports of nerve injury caused by ropivacaine. The mechanism for nerve injury induced by ropivacaine has not been fully clarified. This study aims to investigate the changes of pain threshold and L3 spinal cord genomics at 6 h and 24 h after intrathecal injection of 0.5% and 1.0% ropivacaine, and to explore the underlying mechanisms for nerve injury caused by ropivacaine.
METHODS:A total of 30 male Sprague Dawley rats weighing 220-260 g were successfully implanted with microspinal catheter. The rats were randomly divided into 5 groups (each n=6): a control group (given saline), a ropivacaine group 1 and a ropivacaine group 2 (both given 1% ropivacaine), a ropivacaine group 3 and a ropivacaine group 4 (both given 0.5% ropivacaine). The rats received continuous intrathecal injection of corresponding drugs at 8.3 μL/h for 24 h via an implanted intrathecal catheter followed by 24 h-pause of injection for the ropivacaine group 2, the ropivacaine group 4 and the control group, 6 h-pause of injection for the ropivacaine group 1 and the ropivacaine group 3. For each group, the observation of behavioral change and the paw withdrawal mechanical threshold (PWMT) was conducted immediately after the injection and again after the pause of injection. After the PWMT observation, the rats were dissected to acquire L3 spinal cords. Illumina sequencing was applied to construct gene libraries. Then the statistical methods were used to find out differentially expressed genes between the groups. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analysis were conducted for those genes. Real-time RT-PCR was used to determine different expressions of some of those genes.
RESULTS:Compared with control group, the PWMT got higher in the ropivacaine group 1-4 and was positively correlated with concentration, negatively correlated with discontinuation duration. Compared with control group, the ropivacaine group 1 had 488 differentially expressed genes, of which 456 were up-regulated and 32 were down-regulated; the ropivacaine group 2 had 1 194 differentially expressed genes, of which 1 092 were up-regulated and 102 were down-regulated; the ropivacaine group 3 had 518 differentially expressed genes, of which 384 were up-regulated and 134 were down-regulated; and the ropivacaine group 4 had 68 differentially expressed genes, of which 46 were up-regulated and 22 were down-regulated. GO enrichment analysis and KEGG signaling pathway analysis showed that most of these differentially expressed genes were related to signaling pathways of inflammatory response.
CONCLUSIONS:After intrathecal injection of 0.5% ropivacaine and 1.0% ropivacaine for 24 h, the differentially expressed genes in L3 spinal cord of rats are mainly related to signaling pathways of inflammatory response.
